Want to see JP:8095 full AI Analyst Report?
Astena Holdings Co.,Ltd. (8095) AI Stock Analysis
Astena Holdings Co.,Ltd.
(TSE/TYO:8095)
The stock's most compelling attribute is its valuation, with a low P/E and above-average dividend yield. Financial performance is mixed: revenue growth and margin expansion are positive, but increased debt and weak cash flow are concerns. Technical indicators support a bullish trend. Overall, the stock presents a moderately bullish opportunity with a score of 65.
Astena Holdings Co.,Ltd. (8095) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 22.60B
- Dividend Yield
- 3.22%
- Average Volume (3M)
- 136.23K
- Price to Earnings (P/E)
- 8.8
- Beta (1Y)
- 0.62
- Revenue Growth
- 13.23%
- EPS Growth
- ―
- Country
- Japan
- Employees
- 1,543
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Medical - Pharmaceuticals
Astena Holdings Co.,Ltd. Business Overview & Revenue Model
Company Description
Astena Holdings Co., Ltd., a Japanese company founded in 1914 and based in Chuo, is engaged in the development and distribution of a wide array of healthcare and chemical products. Its Fine Chemical division specializes in manufacturing and selling a...
How the Company Makes Money
null
Astena Holdings Co.,Ltd. Financial Statement Overview
Summary
Revenue has grown 8% in the latest year with gross margin improving from 22% to 35%, but operating and net margins remain modest. Balance sheet leverage increased (debt/equity from 0.59 to 0.83) and free cash flow generation is weak. Overall financial health is moderate.
Income Statement
65PositiveBalance Sheet
55NeutralCash Flow
50Neutral| Breakdown | TTM | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.74B | 62.74B | 57.99B | 51.98B | 49.64B | 72.32B |
| Gross Profit | 21.87B | 21.87B | 19.37B | 16.32B | 15.44B | 16.60B |
| EBITDA | 5.55B | 5.51B | 849.75M | 4.17B | 3.60B | 4.97B |
| Net Income | 2.19B | 2.19B | -2.53B | 1.16B | 579.60M | 1.74B |
Balance Sheet | ||||||
| Total Assets | 75.44B | 75.44B | 64.60B | 67.25B | 63.55B | 63.55B |
| Cash, Cash Equivalents and Short-Term Investments | 10.19B | 10.19B | 6.10B | 6.88B | 6.93B | 10.93B |
| Total Debt | 22.65B | 22.65B | 14.99B | 16.99B | 15.05B | 15.16B |
| Total Liabilities | 48.04B | 48.04B | 39.29B | 38.65B | 36.48B | 36.55B |
| Stockholders Equity | 27.08B | 27.08B | 25.17B | 28.42B | 26.99B | 27.00B |
Cash Flow | ||||||
| Free Cash Flow | 500.00M | 500.00M | 1.65B | -2.52B | -3.77B | -2.14B |
| Operating Cash Flow | 3.39B | 3.39B | 4.85B | 1.64B | -742.42M | 1.35B |
| Investing Cash Flow | -5.55B | -5.55B | -2.94B | -2.83B | -2.22B | -4.38B |
| Financing Cash Flow | 6.19B | 6.19B | -2.65B | 1.08B | -1.09B | 6.35B |
Astena Holdings Co.,Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:8095, the sentiment is Positive. The current price of 559.00 is above the 20-day moving average (MA) of 534.30, above the 50-day MA of 532.18, and above the 200-day MA of 498.09, indicating a bullish trend. The MACD of 3.43 indicates Negative momentum. The RSI at 66.73 is Neutral, neither overbought nor oversold. The STOCH value of 86.93 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:8095.
Astena Holdings Co.,Ltd. Peers Comparison
Overall Rating
- JP:809565Neutral
JP:435057Neutral
JP:341752Neutral
JP:279643Neutral
JP:489038Underperform
JP:190A32Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:8095 | 65Neutral | JPY 22.60B | 8.82 | ― | 3.22% | 13.23% | ― |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| JP:4350 | 57Neutral | JPY 16.87B | 18.82 | ― | 2.15% | 8.19% | -25.81% |
| JP:3417 | 52Neutral | JPY 13.41B | 17.70 | ― | 3.09% | 2.87% | -73.55% |
| JP:2796 | 43Neutral | JPY 5.89B | 59.01 | ― | 2.79% | 7.64% | ― |
| JP:4890 | 38Underperform | JPY 6.31B | -9.03 | ― | ― | -71.21% | -485.42% |
| JP:190A | 32Underperform | JPY 3.79B | -2.48 | ― | ― | ― | 24.21% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:8095 | Astena Holdings Co.,Ltd. | 559.00 | 108.30 | 24.03% | |
| JP:2796 | Pharmarise Holdings Corp. | 501.00 | -10.24 | -2.00% | |
| JP:3417 | Ohki Health Care Holdings, Inc. | 972.00 | -403.75 | -29.35% | |
| JP:4350 | Medical System Network Co., Ltd. | 559.00 | 78.00 | 16.22% | |
| JP:4890 | Tsubota Laboratory Incorporated | 243.00 | -84.00 | -25.69% | |
| JP:190A | Chordia Therapeutics Inc. | 49.00 | -62.00 | -55.86% |
Astena Holdings Co.,Ltd. Corporate Events
Astena Holdings Secures ¥4.3 Billion Loan With Covenants to Fund Ikeda Industries Acquisition
Astena Holdings Co., Ltd. has disclosed that it entered into a monetary loan agreement in December 2025 to finance its subsidiary IWAKI CO., LTD.’s acquisition of Ikeda Industries Corporation, with funds drawn down later that month. The loan, t...
Astena Holdings Confirms Special Account Settlement and Maintains Stable Dividend Policy
Astena Holdings Co., Ltd., a TSE Prime Market-listed diversified group, manages shareholder returns under a stable, performance-linked dividend framework targeting a minimum DOE of 1.5% and a payout ratio of about 30%. Guided by its Astena 2030 ̶...
Astena Holdings Beats H1 Forecasts on AI-Driven Chemical Demand
Astena Holdings reported that its results for the six months ended May 31, 2026 exceeded earlier forecasts, with net sales of ¥34.57 billion and profits significantly above guidance. Operating profit rose to ¥2.29 billion versus a ¥1.6...
Astena Holdings Posts Higher First-Half Earnings and Confirms Dividend and Full-Year Outlook
Astena Holdings reported consolidated net sales of ¥34.566 billion for the six months ended May 31, 2026, up 14.8% year on year, with operating profit rising 3.2% to ¥2.294 billion and profit attributable to owners of parent increasing 10.0...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 06, 2026